| 1 | against | 28,303 |
| 2 | a-resistant | 3 |
| 3 | affordable.-william | 2 |
| 4 | amoung | 2 |
| 5 | chemo-thermal | 2 |
| 6 | maternally-transmitted | 2 |
| 7 | rna-treated | 2 |
| 8 | vaccine-derived | 2 |
| 9 | '… | 1 |
| 10 | .-ezra | 1 |
| 11 | 1-madin-darby | 1 |
| 12 | 15,611 | 1 |
| 13 | 2,943 | 1 |
| 14 | 3-arylcoumarin-tetracyclic | 1 |
| 15 | 35kd | 1 |
| 16 | 63-48 | 1 |
| 17 | 80.8/100,000 | 1 |
| 18 | a1/a2a | 1 |
| 19 | a2e-laden | 1 |
| 20 | aganist | 1 |
| 21 | ck-14+ | 1 |
| 22 | collagen-grafted | 1 |
| 23 | colony-reared | 1 |
| 24 | conditions-20 | 1 |
| 25 | csl362-mediated | 1 |
| 26 | d-hormone-prodrug | 1 |
| 27 | decompensating | 1 |
| 28 | determinant-containing | 1 |
| 29 | doxycycline/placebo | 1 |
| 30 | effect.no | 1 |
| 31 | fears/misconceptions | 1 |
| 32 | flag™-tagged | 1 |
| 33 | for≤48 | 1 |
| 34 | guidelines.this | 1 |
| 35 | heat-denaturing | 1 |
| 36 | immunity.along | 1 |
| 37 | in16 | 1 |
| 38 | index/clinical | 1 |
| 39 | inhibin/activin-subunits | 1 |
| 40 | inmaintaining | 1 |
| 41 | invarious | 1 |
| 42 | iron-exposed | 1 |
| 43 | k91hg-ce | 1 |
| 44 | lyase-expressing | 1 |
| 45 | management.of | 1 |
| 46 | mcf7/ic50 | 1 |
| 47 | mda-mb231/b02 | 1 |
| 48 | mek-induced | 1 |
| 49 | models.1 | 1 |
| 50 | ms-identified | 1 |
| 51 | nonmetazoan | 1 |
| 52 | of/against | 1 |
| 53 | perforatumthymus | 1 |
| 54 | pglea-producing | 1 |
| 55 | pkc-ζ | 1 |
| 56 | placental-infant | 1 |
| 57 | post-dtap-ipv-hep | 1 |
| 58 | practices-recommended | 1 |
| 59 | pre-bound | 1 |
| 60 | prepositus | 1 |
| 61 | promoter-regulating | 1 |
| 62 | reprieving | 1 |
| 63 | rhyzopertha | 1 |
| 64 | right-shifted | 1 |
| 65 | scaleby | 1 |
| 66 | score-28-c-reactive | 1 |
| 67 | score-c-reactive | 1 |
| 68 | self-immobilized | 1 |
| 69 | services-confirmed | 1 |
| 70 | sulfate-resistant | 1 |
| 71 | tetrocarcin | 1 |
| 72 | thioglycosyl | 1 |
| 73 | titer.only | 1 |
| 74 | transcriptionally-competent | 1 |
| 75 | translationally-arrested | 1 |
| 76 | treatment/eight | 1 |
| 77 | tubastatin | 1 |
| 78 | usage-improved | 1 |
| 79 | σ*/π* | 1 |
| 1 | '… | 1 |
| 2 | .-ezra | 1 |
| 3 | 1-madin-darby | 1 |
| 4 | 15,611 | 1 |
| 5 | 2,943 | 1 |
| 6 | 3-arylcoumarin-tetracyclic | 1 |
| 7 | 35kd | 1 |
| 8 | 63-48 | 1 |
| 9 | 80.8/100,000 | 1 |
| 10 | a-resistant | 3 |
| 11 | a1/a2a | 1 |
| 12 | a2e-laden | 1 |
| 13 | affordable.-william | 2 |
| 14 | against | 28,303 |
| 15 | aganist | 1 |
| 16 | amoung | 2 |
| 17 | chemo-thermal | 2 |
| 18 | ck-14+ | 1 |
| 19 | collagen-grafted | 1 |
| 20 | colony-reared | 1 |
| 21 | conditions-20 | 1 |
| 22 | csl362-mediated | 1 |
| 23 | d-hormone-prodrug | 1 |
| 24 | decompensating | 1 |
| 25 | determinant-containing | 1 |
| 26 | doxycycline/placebo | 1 |
| 27 | effect.no | 1 |
| 28 | fears/misconceptions | 1 |
| 29 | flag™-tagged | 1 |
| 30 | for≤48 | 1 |
| 31 | guidelines.this | 1 |
| 32 | heat-denaturing | 1 |
| 33 | immunity.along | 1 |
| 34 | in16 | 1 |
| 35 | index/clinical | 1 |
| 36 | inhibin/activin-subunits | 1 |
| 37 | inmaintaining | 1 |
| 38 | invarious | 1 |
| 39 | iron-exposed | 1 |
| 40 | k91hg-ce | 1 |
| 41 | lyase-expressing | 1 |
| 42 | management.of | 1 |
| 43 | maternally-transmitted | 2 |
| 44 | mcf7/ic50 | 1 |
| 45 | mda-mb231/b02 | 1 |
| 46 | mek-induced | 1 |
| 47 | models.1 | 1 |
| 48 | ms-identified | 1 |
| 49 | nonmetazoan | 1 |
| 50 | of/against | 1 |
| 51 | perforatumthymus | 1 |
| 52 | pglea-producing | 1 |
| 53 | pkc-ζ | 1 |
| 54 | placental-infant | 1 |
| 55 | post-dtap-ipv-hep | 1 |
| 56 | practices-recommended | 1 |
| 57 | pre-bound | 1 |
| 58 | prepositus | 1 |
| 59 | promoter-regulating | 1 |
| 60 | reprieving | 1 |
| 61 | rhyzopertha | 1 |
| 62 | right-shifted | 1 |
| 63 | rna-treated | 2 |
| 64 | scaleby | 1 |
| 65 | score-28-c-reactive | 1 |
| 66 | score-c-reactive | 1 |
| 67 | self-immobilized | 1 |
| 68 | services-confirmed | 1 |
| 69 | sulfate-resistant | 1 |
| 70 | tetrocarcin | 1 |
| 71 | thioglycosyl | 1 |
| 72 | titer.only | 1 |
| 73 | transcriptionally-competent | 1 |
| 74 | translationally-arrested | 1 |
| 75 | treatment/eight | 1 |
| 76 | tubastatin | 1 |
| 77 | usage-improved | 1 |
| 78 | vaccine-derived | 2 |
| 79 | σ*/π* | 1 |
| 1 | σ*/π* | 1 |
| 2 | ck-14+ | 1 |
| 3 | 80.8/100,000 | 1 |
| 4 | conditions-20 | 1 |
| 5 | mcf7/ic50 | 1 |
| 6 | models.1 | 1 |
| 7 | 15,611 | 1 |
| 8 | mda-mb231/b02 | 1 |
| 9 | 2,943 | 1 |
| 10 | in16 | 1 |
| 11 | 63-48 | 1 |
| 12 | for≤48 | 1 |
| 13 | a1/a2a | 1 |
| 14 | rhyzopertha | 1 |
| 15 | .-ezra | 1 |
| 16 | 3-arylcoumarin-tetracyclic | 1 |
| 17 | mek-induced | 1 |
| 18 | practices-recommended | 1 |
| 19 | flag™-tagged | 1 |
| 20 | ms-identified | 1 |
| 21 | services-confirmed | 1 |
| 22 | colony-reared | 1 |
| 23 | iron-exposed | 1 |
| 24 | rna-treated | 2 |
| 25 | csl362-mediated | 1 |
| 26 | collagen-grafted | 1 |
| 27 | right-shifted | 1 |
| 28 | translationally-arrested | 1 |
| 29 | maternally-transmitted | 2 |
| 30 | vaccine-derived | 2 |
| 31 | usage-improved | 1 |
| 32 | self-immobilized | 1 |
| 33 | 35kd | 1 |
| 34 | pre-bound | 1 |
| 35 | k91hg-ce | 1 |
| 36 | score-28-c-reactive | 1 |
| 37 | score-c-reactive | 1 |
| 38 | management.of | 1 |
| 39 | pglea-producing | 1 |
| 40 | inmaintaining | 1 |
| 41 | determinant-containing | 1 |
| 42 | heat-denaturing | 1 |
| 43 | lyase-expressing | 1 |
| 44 | promoter-regulating | 1 |
| 45 | decompensating | 1 |
| 46 | reprieving | 1 |
| 47 | immunity.along | 1 |
| 48 | amoung | 2 |
| 49 | d-hormone-prodrug | 1 |
| 50 | index/clinical | 1 |
| 51 | chemo-thermal | 2 |
| 52 | thioglycosyl | 1 |
| 53 | affordable.-william | 2 |
| 54 | nonmetazoan | 1 |
| 55 | a2e-laden | 1 |
| 56 | tetrocarcin | 1 |
| 57 | tubastatin | 1 |
| 58 | doxycycline/placebo | 1 |
| 59 | effect.no | 1 |
| 60 | post-dtap-ipv-hep | 1 |
| 61 | guidelines.this | 1 |
| 62 | fears/misconceptions | 1 |
| 63 | inhibin/activin-subunits | 1 |
| 64 | perforatumthymus | 1 |
| 65 | invarious | 1 |
| 66 | prepositus | 1 |
| 67 | treatment/eight | 1 |
| 68 | placental-infant | 1 |
| 69 | a-resistant | 3 |
| 70 | sulfate-resistant | 1 |
| 71 | transcriptionally-competent | 1 |
| 72 | aganist | 1 |
| 73 | against | 28,303 |
| 74 | of/against | 1 |
| 75 | scaleby | 1 |
| 76 | 1-madin-darby | 1 |
| 77 | titer.only | 1 |
| 78 | '… | 1 |
| 79 | pkc-ζ | 1 |